Latest news
25 items- NEWSBiofrontera AG Says Will Terminate Its U.S. ADS Program-Reuters
- SECSEC Form EFFECT filed by Biofrontera AGEFFECT - Biofrontera AG (0001712641) (Filer)
- SECSEC Form 15F-12B filed by Biofrontera AG15F-12B - Biofrontera AG (0001712641) (Filer)
- SECSEC Form POS AM filed by Biofrontera AGPOS AM - Biofrontera AG (0001712641) (Filer)
- SECSEC Form S-8 POS filed by Biofrontera AGS-8 POS - Biofrontera AG (0001712641) (Filer)
- 13D/GSEC Form SC 13D/A filed by Biofrontera AG (Amendment)SC 13D/A - Biofrontera AG (0001712641) (Subject)
- SECSEC Form 25 filed by Biofrontera AG25 - Biofrontera AG (0001712641) (Filer)
- SECSEC Form 6-K filed by Biofrontera AG6-K - Biofrontera AG (0001712641) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.4 million. Biofrontera (NASDAQ:BFRA) shares rose 17.21% to $3.2. The market value of their outstanding shares is at $90.7 million. Mainz Biomed (NASDAQ:MYNZ) stock moved upwards by 14.19% to $15.45. The company's market cap stands at $212.2 million. Also check this: Tesla And 4 Other Stocks Sold By Insiders Hims & Hers Health (NYSE:HIMS) shares rose 12.61% to $4.73. The company's market cap stands at $969.6 million. As per the press release, Q4 earnings came out yesterday. NanoVibronix (NASDAQ:NAOV) shares incre
- SECSEC Form 6-K filed by Biofrontera AG6-K - Biofrontera AG (0001712641) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's Pre-Market SessionGainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9 million. Paratek Pharmaceuticals (NASDAQ:PRTK) stock rose 9.76% to $4.27. The market value of their outstanding shares is at $214.3 million. INmune Bio (NASDAQ:INMB) shares increased by 9.38% to $12.0. The market value of their outstanding shares is at $214.1 million. Revelation Biosciences (NASDAQ:REVB) stock rose 7.17% to $2.39. The company's market cap stands at $34.0 million. Black Diamond Therapeutic (NASDAQ:BDTX) stock moved upwards by 6.95% to $4.0. The market value of their outstanding shares is at $144.9 millio
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5 million. The company's, Q1 earnings came out 3 days ago. Biofrontera (NASDAQ:BFRA) stock rose 11.85% to $3.49. The market value of their outstanding shares is at $98.9 million. Paratek Pharmaceuticals (NASDAQ:PRTK) stock rose 9.76% to $4.27. The company's market cap stands at $214.3 million. Revelation Biosciences (NASDAQ:REVB) stock rose 9.41% to $2.44. The market value of their outstanding shares is at $34.7 million. INmune Bio (NASDAQ:INMB) stock rose 9.38% to $12.0. The market value of their outstanding shares is at $21
- NEWSBiofrontera Shares Resume Trading, Move Higher
- NEWSBiofrontera Shares Halted On Circuit Breaker; Down 22%
- NEWSBiofrontera Shares Resume Trade, Down ~30%
- NEWSBiofrontera Shares To Resume Trade At 2:35 p.m. EST
- NEWSBiofrontera To Delist Its ADS From NasdaqBiofrontera AG (the “Company”) (NASDAQ:BFRA, Frankfurt Stock Exchange: B8F))), an international biopharmaceutical company, decided today its American Depositary Shares (“ADS”) should be delisted from the Nasdaq Capital Market (“Nasdaq”) and its reporting obligations with the Securities and Exchange Commission (“SEC”) should be deregistered and terminated. The main purpose of the delisting is to reduce complexity in financial reporting and administrative costs. Biofrontera AG intends to maintain an amended ADS program on a Level I basis, which will allow investors to continue to hold their securities in the form of ADSs and trade the ADS on the U.S. over-the-counter (OTC) market. The ADSs wi
- PRBiofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costsLeverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the "Company") (NASDAQ:BFRA, Frankfurt Stock Exchange: B8F))), an international biopharmaceutical company, decided today its American Depositary Shares ("ADS") should be delisted from the Nasdaq Capital Market ("Nasdaq") and its reporting obligations with the Securities and Exchange Commission ("SEC") should be deregistered and terminated. The main purpose of the delisting is to reduce complexity in financial reporting and administrative costs. Biofrontera AG intends to maintain an amended ADS program on a Level I basis, which will allow investors to continue to hold their securities in the form of ADSs and trade the
- NEWSBiofrontera Shares Halted On Code News Pending
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Doximity (NYSE:DOCS) shares increased by 23.7% to $61.61 during Wednesday's regular session. Doximity's stock is trading at a volume of 8.5 million shares as of 12:30 EST. This is 319.2% of its average full-day volume over the last 100 days. The company's market cap stands at $11.5 billion. The company's, Q3 earnings came out yesterday. Gracell Biotechnologies (NASDAQ:GRCL) shares moved upwards by 18.85% to $3.62. Gracell Biotechnologies's stock is trading at a volume of 577.4K shares as of 12:30 EST. This is 93.2% of its average full-day volume over the last 100 days. The company's market cap stands at $244.6 million. Deciphera Pharmaceuticals (NASDAQ:DCPH) shares rose 16.91
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 13.6% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1 million. Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 13.22% to $2.14. The market value of their outstanding shares is at $66.3 million. Check out this: Executives Buy Around $64M Of 3 Stocks Biofrontera (NASDAQ:BFRA) stock increased by 13.08% to $3.37. The market value of their outstanding shares is at $95.5 million. Avrobio (NASDAQ:AVRO) shares moved upwards by 11.93% to $1.97. The market value of their outstanding shares is at $85.9 million. Doximity (NYSE:DOCS) shares increased by 11.82% to $55.7. The mark
- SECSEC Form 6-K filed by Biofrontera AG6-K - Biofrontera AG (0001712641) (Filer)
- NEWSStocks That Hit 52-Week Lows On TuesdayOn Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap, to set a new 52-week low. Yunhong CTI (NASDAQ:CTIB) was the smallest company by market cap to set a new 52-week low. Aerojet Rocketdyne Hldgs (NYSE:AJRD)'s stock made the biggest move downwards, diving 14.58% to reach a new 52-week low. Lixiang Education Holding (NASDAQ:LXEH) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low. Stocks dropping to new 52-week lows on Tuesday: Credit Suisse Group (NYSE:CS) shares were down 4.44% for the day, having m
- SECSEC Form 6-K filed by Biofrontera AG6-K - Biofrontera AG (0001712641) (Filer)
- NEWSUPDATE: Biofrontera Is No Longer Considered A Subsidiary Of Biofrontera AG
BFRA FAQ
6 questionsWhat does Biofrontera AG do?
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In...Where does BFRA stock trade?
Biofrontera AG (BFRA) is listed on NASDAQ.What sector and industry is BFRA in?
Biofrontera AG operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Biofrontera AG go public?
Biofrontera AG (BFRA) completed its IPO in 2018.What companies are similar to BFRA?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare BFRA side-by-side with any of them on Quantisnow.How can I track BFRA on Quantisnow?
Quantisnow aggregates Biofrontera AG's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BFRA to receive live email and push alerts on every new disclosure.